Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
Saved in:
| Title: | Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant. |
|---|---|
| Authors: | Zakaria, Z, Tivnan, A1, Flanagan, L1, Murray, D W1, Salvucci, M1, Stringer, B W2, Day, B W2, Boyd, A W2, Kögel, D3, Rehm, M1, O'Brien, D F4, Byrne, A T1, Prehn, J H M1, Kögel, D3 (AUTHOR) |
| Source: | British Journal of Cancer. 1/19/2016, Vol. 114 Issue 2, p188-198. 11p. 1 Diagram, 5 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
